ClinicalTrials.Veeva

Menu

Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer

P

Peking University

Status

Unknown

Conditions

Gastric Cancer

Treatments

Other: detection of CTCs

Study type

Observational

Funder types

Other

Identifiers

NCT01848015
CGOG5003

Details and patient eligibility

About

To assess the predictive value of circulating tumor cells (CTCs) for recurrence of advanced gastric cancer after radical resection.

To identify the relationship between the detection of circulation tumor cells and recurrence patterns of gastric cancer after radical resection.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Having signed informed consent
  • Age≥ 18 years old
  • Histologically confirmed gastric adenocarcinoma
  • Preoperative clinical examination and imaging indicating operable disease
  • complete resection (R0 resection)
  • D2 or D2+ resection

Exclusion criteria

  • Other tumor type than adenocarcinoma
  • Patients who have been given preoperative chemotherapy/chemoradiation.
  • Staging investigations or intraoperative exploration indicating inoperable disease
  • R1 or R2 resection
  • D0 or D1 resection
  • Patients unreliable for follow up
  • Past history of malignancy

Trial design

200 participants in 1 patient group

CTCs positive
Treatment:
Other: detection of CTCs

Trial contacts and locations

1

Loading...

Central trial contact

Lin Shen, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems